Trial Profile
Safety of panitumumab monotherapy in metastatic colorectal cancer patients over 70 years old
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Aug 2015
Price :
$35
*
At a glance
- Drugs Panitumumab (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 12 Aug 2015 New trial record